BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tétreault P, Besserer-offroy É, Brouillette RL, René A, Murza A, Fanelli R, Kirby K, Parent AJ, Dubuc I, Beaudet N, Côté J, Longpré J, Martinez J, Cavelier F, Sarret P. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog. European Journal of Pharmacology 2020;882:173174. [DOI: 10.1016/j.ejphar.2020.173174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sampaio-Dias IE, Santejo M, Silva-Reis SC, Liz MA, Alcoholado C, Algarra M, García-Mera X, Rodríguez-Borges JE. Design, Synthesis, and Biological Evaluation of Hybrid Glypromate Analogues Using 2-Azanorbornane as a Prolyl and Pipecolyl Surrogate. ACS Chem Neurosci 2021;12:3615-24. [PMID: 34515466 DOI: 10.1021/acschemneuro.1c00339] [Reference Citation Analysis]
2 Obeng S, Hiranita T, León F, McMahon LR, McCurdy CR. Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. J Med Chem 2021;64:6523-48. [PMID: 33956427 DOI: 10.1021/acs.jmedchem.1c00028] [Reference Citation Analysis]
3 Vivancos M, Fanelli R, Besserer-Offroy É, Beaulieu S, Chartier M, Resua-Rojas M, Mona CE, Previti S, Rémond E, Longpré JM, Cavelier F, Sarret P. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia. Behav Brain Res 2021;405:113189. [PMID: 33607165 DOI: 10.1016/j.bbr.2021.113189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Besserer-Offroy É, Tétreault P, Brouillette RL, René A, Murza A, Fanelli R, Kirby K, Parent A, Dubuc I, Beaudet N, Côté J, Longpré JM, Martinez J, Cavelier F, Sarret P. Data set describing the in vitro biological activity of JMV2009, a novel silylated neurotensin(8-13) analog. Data Brief 2020;31:105884. [PMID: 32637491 DOI: 10.1016/j.dib.2020.105884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]